គេហទំព័រសុខភាព-អាហារ និងអភិវឌ្ឍន៍ ត្រូវបានបង្កើតឡើងដោយ PPM-Confirel Group

11th edition of the Kinal Prize: Awards ceremony on December 16th, 2023

កាលបរិច្ឆេទ: ១៩ ធ្នូ ២០២៣ / សុខភាព

The best research by students in medicine and pharmaceutical studies in Phnom Penh universities will be awarded on Saturday, December 16th, during the awards ceremony for the 2023 Kinal Prize, presided over by Her Excellency Ph. Var Puthneath, Secretary of State of the Ministry of Health, and Dr. Hay Ly Eang, president of the Kinal Foundation.

Among 15 applications, the Kinal 2023 prize jury selected 10 for the final of the competition. This selection was made on the basis of research proposals around the theme chosen for this 2023 edition: “The relationships between stress and pain”.

The selected teams come from the faculties of pharmacy, dentistry and medicine of four universities: Universities of Health Sciences, Universities of Health Sciences of the Royal Khmer Armed Forces, Puthisastra University and International University.

The jury for the Kinal Prize, presided over by Prof. Chhea Chhorvann, Director of National Institute of Health, will hear presentations from selected groups for the final round in the morning and choose the three winning teams. Then the awards ceremony will take place.

Created in 2013, the Kinal Prize strives to encourage Cambodian students in health sciences to conduct research projects in accordance with international scientific standards in order, for students, to reach their best potential in their field, to help them to find work that matches their talents as they embark on their careers and to contribute to the development of scientific research in Cambodia.

This prize encourages the young generation to follow in the footsteps of Dr. Kok Sok Kim, who, 64 years ago, launched the pain killer medicine Kinal, the first drug produced in Cambodia released just after the country declared its independence.

The Kinal Prize is organized by The Kinal Foundation which is supported by PPM, Cambodia’s premier pharmaceutical company.